| dbo:abstract |
أسيبيموكس (بالإنجليزية: Acipimox) هي مادة مشتقة من الناياسين وتستخدم كدواء لتخفيض الكوليسترول . (ar) Acipimox (trade name Olbetam in Europe) is a niacin derivative used as a lipid-lowering agent. It reduces triglyceride levels and increases HDL cholesterol.It may have less marked adverse effects than niacin, although it is unclear whether the recommended dose is as effective as standard doses of niacin. (en) Fármaco hipolipemiante derivado del ácido nicotínico. (es) L' acipimox è un farmaco che si utilizza in caso di specifiche iperlipidemie (tipo IIb e IV). (it) Acypimoks (łac. acipimoksum) – wielofunkcyjny organiczny związek chemiczny, analog kwasu nikotynowego, stosowany jako lek uzupełniający w leczeniu hipercholesterolemii oraz hipertrójglicerydemii. (pl) Acipimox é um fármaco derivado da niacina utilizado como um agente hipolipidémico. (pt) |
| dbo:alternativeName |
Olbetam (en) |
| dbo:bioavailability |
100.000000 (xsd:float) |
| dbo:casNumber |
51037-30-0 |
| dbo:chEMBL |
345714 |
| dbo:fdaUniiCode |
K9AY9IR2SD |
| dbo:kegg |
D07190 |
| dbo:pubchem |
5310993 |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Acipimox.svg?width=300 |
| dbo:wikiPageID |
12742782 (xsd:integer) |
| dbo:wikiPageLength |
5351 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1106663368 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Prostaglandin_D2 dbr:Indigestion dbc:Carboxylic_acids dbr:Low-density_lipoprotein dbr:Gout dbr:Myocardial_infarction dbr:Niacin_receptor_1 dbr:Statin dbr:Fatty_acid dbr:Triglyceride dbr:Peptic_ulcer dbr:Lipid-lowering_agent dbr:Acute_decompensated_heart_failure dbc:Amine_oxides dbr:Fibrates dbr:Chronic_kidney_disease dbr:Flushing_(physiology) dbc:Hypolipidemic_agents dbc:Pyrazines dbr:Aspirin dbr:Kidney dbr:High-density_lipoprotein dbr:Niacin_(substance) dbr:Very_low-density_lipoprotein dbr:Myalgia dbr:Palpitations dbr:Triglyceride_lipase dbr:Glucose_tolerance dbr:Plasma_protein |
| dbp:alt |
Ball-and-stick model (en) Skeletal formula (en) |
| dbp:atcPrefix |
10.0 |
| dbp:atcSuffix |
AD06 (en) |
| dbp:bioavailability |
100.0 |
| dbp:c |
6 (xsd:integer) |
| dbp:casNumber |
51037 (xsd:integer) |
| dbp:chembl |
345714 (xsd:integer) |
| dbp:chemspiderid |
4470534 (xsd:integer) |
| dbp:eliminationHalfLife |
7200.0 -50400.0 |
| dbp:excretion |
dbr:Kidney |
| dbp:h |
6 (xsd:integer) |
| dbp:image |
Acipimox-3D-spacefill.png (en) |
| dbp:iupacName |
5 (xsd:integer) |
| dbp:iupharLigand |
1596 (xsd:integer) |
| dbp:kegg |
D07190 (en) |
| dbp:legalUk |
POM (en) |
| dbp:metabolism |
None (en) |
| dbp:n |
2 (xsd:integer) |
| dbp:o |
3 (xsd:integer) |
| dbp:proteinBound |
None (en) |
| dbp:pubchem |
5310993 (xsd:integer) |
| dbp:routesOfAdministration |
Oral (en) |
| dbp:smiles |
[O-][n+]1cC (en) |
| dbp:stdinchi |
1 (xsd:integer) |
| dbp:stdinchikey |
DJQOOSBJCLSSEY-UHFFFAOYSA-N (en) |
| dbp:tradename |
Olbetam (en) |
| dbp:unii |
K9AY9IR2SD (en) |
| dbp:verifiedrevid |
442738806 (xsd:integer) |
| dbp:watchedfields |
changed (en) |
| dbp:width |
180 (xsd:integer) |
| dbp:wikiPageUsesTemplate |
dbt:Citation_needed dbt:Drugbox dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Ebicite dbt:Fdacite dbt:Keggcite dbt:Stdinchicite dbt:Drugs.com dbt:Lipid_modifying_agents |
| dcterms:subject |
dbc:Carboxylic_acids dbc:Amine_oxides dbc:Hypolipidemic_agents dbc:Pyrazines |
| gold:hypernym |
dbr:Doses |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatAmineOxides yago:WikicatCarboxylicAcids yago:WikicatMolecularFormulas yago:Abstraction100002137 yago:Acid114607521 yago:CarboxylicAcid114739360 yago:Chemical114806838 yago:Communication100033020 yago:Compound114818238 yago:Formula106816935 yago:Material114580897 yago:Matter100020827 yago:Message106598915 yago:MolecularFormula106817173 yago:Oxide114971519 yago:Part113809207 yago:PhysicalEntity100001930 yago:Relation100031921 dbo:Drug yago:Statement106722453 yago:Substance100019613 umbel-rc:DrugProduct |
| rdfs:comment |
أسيبيموكس (بالإنجليزية: Acipimox) هي مادة مشتقة من الناياسين وتستخدم كدواء لتخفيض الكوليسترول . (ar) Acipimox (trade name Olbetam in Europe) is a niacin derivative used as a lipid-lowering agent. It reduces triglyceride levels and increases HDL cholesterol.It may have less marked adverse effects than niacin, although it is unclear whether the recommended dose is as effective as standard doses of niacin. (en) Fármaco hipolipemiante derivado del ácido nicotínico. (es) L' acipimox è un farmaco che si utilizza in caso di specifiche iperlipidemie (tipo IIb e IV). (it) Acypimoks (łac. acipimoksum) – wielofunkcyjny organiczny związek chemiczny, analog kwasu nikotynowego, stosowany jako lek uzupełniający w leczeniu hipercholesterolemii oraz hipertrójglicerydemii. (pl) Acipimox é um fármaco derivado da niacina utilizado como um agente hipolipidémico. (pt) |
| rdfs:label |
أسيبيموكس (ar) Acipimox (en) Acipimox (es) Acipimox (it) Acypimoks (pl) Acipimox (pt) |
| owl:sameAs |
freebase:Acipimox yago-res:Acipimox wikidata:Acipimox dbpedia-ar:Acipimox dbpedia-es:Acipimox dbpedia-it:Acipimox dbpedia-pl:Acipimox dbpedia-pt:Acipimox dbpedia-ro:Acipimox dbpedia-sh:Acipimox dbpedia-sr:Acipimox dbpedia-th:Acipimox dbpedia-vi:Acipimox https://global.dbpedia.org/id/2DHMV |
| prov:wasDerivedFrom |
wikipedia-en:Acipimox?oldid=1106663368&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Acipimox-3D-spacefill.png wiki-commons:Special:FilePath/Acipimox.svg |
| foaf:isPrimaryTopicOf |
wikipedia-en:Acipimox |
| is dbo:wikiPageRedirects of |
dbr:C6H6N2O3 dbr:ATC_code_C10AD06 dbr:ATCvet_code_QC10AD06 dbr:Olbetam |
| is dbo:wikiPageWikiLink of |
dbr:Leptin dbr:Caloric_restriction_mimetic dbr:C6H6N2O3 dbr:Lipid-lowering_agent dbr:ATC_code_C10AD06 dbr:ATCvet_code_QC10AD06 dbr:ATC_code_C10 dbr:List_of_drugs:_Ac dbr:Olbetam |
| is foaf:primaryTopic of |
wikipedia-en:Acipimox |
